4nge

Publication Abstract from PubMed

Human presequence protease (hPreP) is an M16 metalloprotease localized in mitochondria. There, hPreP facilitates proteostasis by utilizing an approximately 13,300-A3 catalytic chamber to degrade a diverse array of potentially toxic peptides, including mitochondrial presequences and beta-amyloid (Abeta), the latter of which contributes to Alzheimer disease pathogenesis. Here, we report crystal structures for hPreP alone and in complex with Abeta, which show that hPreP uses size exclusion and charge complementation for substrate recognition. These structures also reveal hPreP-specific features that permit a diverse array of peptides, with distinct distributions of charged and hydrophobic residues, to be specifically captured, cleaved, and have their amyloidogenic features destroyed. SAXS analysis demonstrates that hPreP in solution exists in dynamic equilibrium between closed and open states, with the former being preferred. Furthermore, Abeta binding induces the closed state and hPreP dimerization. Together, these data reveal the molecular basis for flexible yet specific substrate recognition and degradation by hPreP.

Molecular Basis of Substrate Recognition and Degradation by Human Presequence Protease.,King JV, Liang WG, Scherpelz KP, Schilling AB, Meredith SC, Tang WJ Structure. 2014 Jun 11. pii: S0969-2126(14)00143-9. doi:, 10.1016/j.str.2014.05.003. PMID:24931469^[2]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.